| General Information of Drug Metabolite (DM) (ID: DM017893) |
| DM Name |
3-cyano-2,6-dihydropyrimidine (CNDP)
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Esterases (ES)
|
DMEN229
|
| Unclear - Unclear |
EMITEFUR
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| EMITEFUR |
DR3081
|
Discontinued in Preregistration |
Solid tumour/cancer |
|
|
| References |
| 1 |
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumors
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
